Company Overview and News

 
Rana Sugars Limited - Shareholders meeting

2018-09-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
507490 RANASUG

 
Sugar stocks trade higher as Cabinet to consider Rs 4,500 crore package for sugar industry

2018-09-26 moneycontrol
Share price of most of the sugar stocks are trading higher on Wednesday as Cabinet is likely to consider the Rs 4,500 crore package for sugar industry today.
BAJAJHIND 507490 590062 RANASUG 500032 ANDHRSUGAR

 
NSE moves sugar stocks, others to T2T

2018-09-24 thehindubusinessline
The NSE has shifted 15 stocks to the restricted trading category from Thursday. These are Simbhaoli Sugars, Mawana Sugars, Sakthi Sugars, Rana Sugars, Ugar Sugar Works, Rajshree Sugars, Spentex Ind, Bedmutha Ind, Flexituff International, Jai Balaji Industries, Kesar Enterprises, Refex Industries, Kothari Sugars and Chemicals, Palash Securities and Precot Meridian. Delivery of shares and payment of consideration are mandatory for trading in these stocks.
KESARENT ALNSE UGARSUGAR 507490 507180 532976 FLEXITUFF 532884 MAWANASUG 530363 523371 533638 SAKHTISUG REFEX RANASUG JAIBALAJI 507315

 
NSE to move 15 companies to restricted trading category from September 27

2018-09-24 moneycontrol
Leading stock exchange NSE will shift 15 firms to the restricted trading category from September 27 as part of a surveillance review.
KESARENT UGARSUGAR 533270 507490 BEDMUTHA 507180 532976 FLEXITUFF 532884 MAWANASUG 530363 523371 521082 533638 SAKHTISUG REFEX RANASUG JAIBALAJI SPENTEX 507315

 
ILFS Transport, Avanti Feeds, Suzlon, Balrampur Chini top gainers among BSE Group A stocks

2018-09-17 moneycontrol
The Indian benchmark indices continued to trade in the red on Monday afternoon with the Nifty50 down 142 points while the Sensex was trading lower by 504 points at 37,586.
BALRAMCHIN SUZLON ZODIACLOTH AVANTI MONSANTO 507490 512573 532667 513023 524084 521163 500038 RANASUG SUEL NBVENTURES

 
Sugar stocks extend gains, zoom 20% after government hikes ethanol price by 25%

2018-09-14 moneycontrol
Sugar stocks are rallying this Friday afternoon and have given robust gains after the government approved hiking the price of ethanol produced directly from sugarcane juice for blending in petrol by 25 percent.
MAWANASUG BALRAMCHIN 523371 532670 SAKHTISUG 507490 500038 RENUKA RANASUG 507315

 
Sugar stocks rally 20% as govt raises ethanol price

2018-09-14 thehindubusinessline
Shares of sugar companies jumped as much as 20 per cent as the government has raised the ethanol price for blending in petrol by 25 per cent.
THIRUSUGAR UTTAMSUGAR 532729 500119 507490 BANARISUG 532610 500041 DWARKESH 507450 532460 SAKHTISUG PONNIERODE RANASUG 507315 DHAMPURSUG

 
Rana Sugars Limited - Book Closure

2018-09-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
507490 RANASUG

 
Rana Sugars Limited - Shareholders meeting

2018-09-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
507490 RANASUG

 
Rana Sugars Limited - Outcome of Board Meeting

2018-08-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
507490 RANASUG

 
Rana Sugars Limited - Clarification - Financial Results

2018-06-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
507490 RANASUG

 
Rana Sugars Limited - Clarification

2018-06-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
507490 RANASUG

 
Rana Sugars Limited - Outcome of Board Meeting

2018-06-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
507490 RANASUG

 
Rana Sugars Limited - Financial Result Updates

2018-06-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
507490 RANASUG

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...